Market Overview

Global Enteral Feeding Devices Market Outlook to 2025 -


The "Enteral
Feeding Devices Market by Product, Age Group, Application and End User -
Global Opportunity Analysis and Industry Forecast, 2018-2025"

report has been added to's

The market was valued at $2,503 million in 2017, and is projected to
reach $3,848 million by 2025 at a CAGR of 5.4% from 2018 to 2025.

Increase in prevalence of several chronic disorders such as cancer,
neurological disorders across the world, upsurge in the adoption of
enteral nutrition, rise in geriatric population, and growth in incidence
of malnutrition cases drive the market.

However, stringent governmental regulations and inadvertent dislodgment
of tubes leading to accidental disabilities and deaths, impede the
market growth.

Conversely, the development of newer products with lesser side effects
and presence of untapped market in the emerging economies are expected
to provide lucrative growth opportunities for the market.

The enteral feeding pumps segment accounted for the largest share in
2017 owing to growth in usage and lesser side effects as compared to
other devices. The enteral syringe segment is expected to grow at the
high CAGR from 2018 to 2025.

The neurological disorder segment is the largest application segment in
the global enteral feeding device market in 2017 and is estimated to
grow at a moderate CAGR during the forecast period. On the other hand,
the cancer segment is anticipated to record a highest CAGR during the
forecast period.

Key Findings

  • The enteral feeding tube segment accounted for nearly one-fifth share
    of the global enteral feeding devices market in 2017
  • The pediatric segment is expected to grow at a CAGR of 6.5% from 2018
    to 2025
  • The gastrointestinal segment accounted for around one-eighth share of
    the global market in 2017
  • North America accounted for around one-third share of the global
    market in 2017
  • LAMEA is expected to provide lucrative market growth opportunities and
    grows with the CAGR of 6% from 2018 to 2025

Company Profiles

  • Abbott Laboratories
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Danone
  • Fresenius SE & Co. KGaA
  • Halyard Health, Inc.
  • Medtronic Plc.
  • Moog Inc.
  • Nestle S.A.

For more information about this report visit

View Comments and Join the Discussion!